Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl B Scheidweiler

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|September 30, 2018
Pharmacodynamic Effects, Pharmacokinetics, and Metabolism of the Synthetic Cannabinoid AM-2201 in Male RatsJeremy Carlier, Ariane Wohlfarth, Bonita D Salmeron, et al.
Journal of Chromatography. A|May 23, 2016
Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometryJeremy Carlier, Karl B Scheidweiler, Ariane Wohlfarth, et al.
Clinical Chemistry|February 12, 2017
Cannabis Edibles: Blood and Oral Fluid Cannabinoid Pharmacokinetics and Evaluation of Oral Fluid Screening Devices for Predicting Δ<sup>9</sup>-Tetrahydrocannabinol in Blood and Oral Fluid following Cannabis Brownie AdministrationMatthew N Newmeyer, Madeleine J Swortwood, Maria Andersson, et al.
Drug Testing and Analysis|September 21, 2016
Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administrationMadeleine J Swortwood, Matthew N Newmeyer, Maria Andersson, et al.
Analytical and Bioanalytical Chemistry|December 3, 2013
In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabisNathalie A Desrosiers, Dayong Lee, Karl B Scheidweiler, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 22, 2013
Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the ratMarta Concheiro, Michael H Baumann, Karl B Scheidweiler, et al.
Analytical Chemistry|December 22, 2012
Development and validation of the first liquid chromatography-tandem mass spectrometry assay for simultaneous quantification of multiple antiretrovirals in meconiumSarah K Himes, Karl B Scheidweiler, Katherine Tassiopoulos, et al.
Clinical Chemistry|September 19, 2013
Cannabinoids in exhaled breath following controlled administration of smoked cannabisSarah K Himes, Karl B Scheidweiler, Olof Beck, et al.
The AAPS Journal|February 28, 2015
Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACAAriane Wohlfarth, Marisol S Castaneto, Mingshe Zhu, et al.
Drug Testing and Analysis|May 16, 2014
High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomesAdarsh S Gandhi, Ariane Wohlfarth, Mingshe Zhu, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Pharmacology and Experimental Therapeutics|September 30, 2018
Pharmacodynamic Effects, Pharmacokinetics, and Metabolism of the Synthetic Cannabinoid AM-2201 in Male RatsJeremy Carlier, Ariane Wohlfarth, Bonita D Salmeron, et al.
Journal of Chromatography. A|May 23, 2016
Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometryJeremy Carlier, Karl B Scheidweiler, Ariane Wohlfarth, et al.
Clinical Chemistry|February 12, 2017
Cannabis Edibles: Blood and Oral Fluid Cannabinoid Pharmacokinetics and Evaluation of Oral Fluid Screening Devices for Predicting Δ<sup>9</sup>-Tetrahydrocannabinol in Blood and Oral Fluid following Cannabis Brownie AdministrationMatthew N Newmeyer, Madeleine J Swortwood, Maria Andersson, et al.
Drug Testing and Analysis|September 21, 2016
Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administrationMadeleine J Swortwood, Matthew N Newmeyer, Maria Andersson, et al.
Analytical and Bioanalytical Chemistry|December 3, 2013
In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabisNathalie A Desrosiers, Dayong Lee, Karl B Scheidweiler, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 22, 2013
Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the ratMarta Concheiro, Michael H Baumann, Karl B Scheidweiler, et al.
Analytical Chemistry|December 22, 2012
Development and validation of the first liquid chromatography-tandem mass spectrometry assay for simultaneous quantification of multiple antiretrovirals in meconiumSarah K Himes, Karl B Scheidweiler, Katherine Tassiopoulos, et al.
Clinical Chemistry|September 19, 2013
Cannabinoids in exhaled breath following controlled administration of smoked cannabisSarah K Himes, Karl B Scheidweiler, Olof Beck, et al.
The AAPS Journal|February 28, 2015
Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACAAriane Wohlfarth, Marisol S Castaneto, Mingshe Zhu, et al.
Drug Testing and Analysis|May 16, 2014
High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomesAdarsh S Gandhi, Ariane Wohlfarth, Mingshe Zhu, et al.
Pageof 7